Gruffydd-Jones, KevinBrusselle, GuyJones, RupertMiravitlles, MarcBaldwin, MichaelStewart, RebeccaRigazio, AnnaDavis, EmilyKeininger, Dorothy L.Price, David2017-07-242017-07-242016Gruffydd-Jones, K, Brusselle, G, Jones, R, Miravitlles, M, Baldwin, M, Stewart, R, Rigazio, A, Davis, E, Keininger, D L & Price, D 2016, 'Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world study', npj Primary Care Respiratory Medicine, vol. 26, 16002. https://doi.org/10.1038/npjpcrm.2016.2http://hdl.handle.net/2164/8984Acknowledgements Samantha Holmes (CircleScience, an Ashfield Company, part of UDG Healthcare plc) and Paul Hutchin (contracted to CircleScience, an Ashfield Company, part of UDG Healthcare plc) provided medical writing assistance. Funding The study was funded by Novartis Pharma AG (Basel, Switzerland).918705engSDG 3 - Good Health and Well-beingR MedicinePulmonary and Respiratory MedicinePublic Health, Environmental and Occupational HealthRChanges in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world studyJournal item10.1038/npjpcrm.2016.2http://www.scopus.com/inward/record.url?scp=84964396920&partnerID=8YFLogxK26